SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--The t:slim X2™ insulin pump from Tandem Diabetes Car

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology compan

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery an

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo

Deutsche Bank analyst Kieran Ryan initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company

Wells Fargo analyst Larry Biegelsen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Equal-Weight

Citigroup analyst Joanne Wuensch maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and

B of A Securities analyst Travis Steed maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutra

Analysts change outlook on top names. Check their ratings & price targets for AVEX, ALMR, TNDM,

Truist Securities analyst Richard Newitter reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a B

Barclays analyst Matt Miksic maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and l

Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion t

Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.30) per share which beat the ana

FDA flags Class I recall for Tandem Mobi insulin pumps tied to software glitch that may halt insulin

TD Cowen analyst Mathew Blackman maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and rais

Goldman Sachs analyst David Roman maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and

MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising c

Analyst ratings changed for top Wall Street names. Morgan Stanley cut Carnival Corp price target, R

Top Wall Street analysts upgraded Carnival Corp, Tandem Diabetes Care, and Union Pacific Corp. Analy

Truist Securities analyst Richard Newitter upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Hold

Piper Sandler upgrades Tandem Diabetes, citing pharmacy shift, international growth, and Mobi launch

Wall Street analysts changed outlook on top names: Morgan Stanley raised Lemonade's PT to $85,

Top Wall Street analysts changed their outlook on top names. Upgrades include LMND, CSIQ, TNDM, ICHR

Piper Sandler analyst Matt O'Brien upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Neutral t

Morgan Stanley analyst Patrick Wood maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Wei

Lake Street analyst Frank Takkinen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Hold to Buy a

Truist Securities analyst Richard Newitter reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a H

U.S. stocks rise after Supreme Court decision on tariffs. Fear & Greed index eases but remains i

Mizuho analyst Anthony Petrone maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and ra

UBS analyst Danielle Antalffy maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and rai